Incyte (INCY) Fair Value & DCF

INCY$122.10+1.80 +1.50%
BiotechnologyLarge CapHigh Quality
Compare
Market cap$24.89BEnterprise value$21.80BRevenue (TTM)$6.01BMarket positionTop 25%

Score

51
Neutral
Value
37
Quality
73
Growth
42

Incyte Corporation (INCY) trades at $122.10 on $24.89B of equity value, with a trailing P/E of 60.78. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.

Incyte (INCY) Fair Value & DCF

INCY price $122.10 +1.80 +1.50%

Ticker
INCY
Price
$122.10
Change
+1.80 +1.50%
Market cap
$24.89B
P/E
60.78
Forward P/E
15.73
Dividend yield
0.00%
Beta
0.78
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
51
Value
37
Quality
73
Growth
42

Stocklytics score rationale: value 37, quality 73, growth 42.

AI Score 65. Incyte Corporation has a market cap of $24.47 billion and a high price-to-earnings ratio of 57.16, indicating potential overvaluation. Despite strong gross profit margins of 92.69% and a solid current ratio of 3.84, the company has reported negative net income in recent quarters, which raises concerns about its profitability and growth sustainability

Insights · Forecast · Financials · Learn

Stocklytics home · Screener